Imatinib mesylate 220127-57-1 99%

we are a pharmaceutical contract development and manufacturing organization (“CDMO”) offering a comprehensive range of pharmaceutical products and services in India and overseas. As one of the leading CDMOs in India, we own the intellectual property for the manufacturing processes of several of our formulations, and our core business is focused on providing end-to-end product development and manufacturing solutions to our clients.

Some of our other services include formulation research and development (“R&D”), preparation and filing of regulatory dossiers in the Indian and global markets, and other testing services.

4 Research and Development (R&D) Units drives our continuous efforts in product development, ensuring innovative solutions.

Quality Assurance：
Compliance, testing, and continuous improvement ensured high standards for our Products.